Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Receivables (2016 - 2021)

Medifast (MED) has disclosed Receivables for 12 consecutive years, with $88000.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Receivables fell 77.44% year-over-year to $88000.0, compared with a TTM value of $88000.0 through Mar 2021, down 77.44%, and an annual FY2020 reading of $584000.0, down 59.36% over the prior year.
  • Receivables was $88000.0 for Q1 2021 at Medifast, down from $584000.0 in the prior quarter.
  • Across five years, Receivables topped out at $1.5 million in Q1 2017 and bottomed at $88000.0 in Q1 2021.
  • Average Receivables over 5 years is $865882.4, with a median of $914000.0 recorded in 2017.
  • The sharpest move saw Receivables soared 75.52% in 2018, then plummeted 77.44% in 2021.
  • Year by year, Receivables stood at $576000.0 in 2017, then surged by 75.52% to $1.0 million in 2018, then surged by 42.14% to $1.4 million in 2019, then crashed by 59.36% to $584000.0 in 2020, then tumbled by 84.93% to $88000.0 in 2021.
  • Business Quant data shows Receivables for MED at $88000.0 in Q1 2021, $584000.0 in Q4 2020, and $647000.0 in Q3 2020.